Francesco Fiorentini

2.5k total citations
40 papers, 1.0k citations indexed

About

Francesco Fiorentini is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Francesco Fiorentini has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Francesco Fiorentini's work include Cancer-related Molecular Pathways (6 papers), Microtubule and mitosis dynamics (5 papers) and Neuroblastoma Research and Treatments (5 papers). Francesco Fiorentini is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Microtubule and mitosis dynamics (5 papers) and Neuroblastoma Research and Treatments (5 papers). Francesco Fiorentini collaborates with scholars based in Italy, United States and France. Francesco Fiorentini's co-authors include S. Consolo, H. Ladinsky, Annamaria Vezzani, Chun Fu Wu, Enrico Pesenti, Massimiliano Germani, Maria Gabriella Brasca, Vincenzo Tortorella, Roberto Perrone and Nicola Antonio Colabufo and has published in prestigious journals such as Blood, Cancer Research and Brain Research.

In The Last Decade

Francesco Fiorentini

40 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesco Fiorentini Italy	19	495	231	204	198	146	40	1.0k
Martin Krüger Germany	13	393 0.8×	106 0.5×	199 1.0×	255 1.3×	61 0.4×	16	1.2k
Roland Neuhaus Germany	16	732 1.5×	191 0.8×	193 0.9×	123 0.6×	43 0.3×	35	1.1k
Karima Bettayeb France	18	731 1.5×	316 1.4×	101 0.5×	397 2.0×	167 1.1×	21	1.5k
Jen‐Shin Song Taiwan	22	625 1.3×	273 1.2×	132 0.6×	346 1.7×	156 1.1×	58	1.4k
Mingzhang Gao United States	22	564 1.1×	263 1.1×	183 0.9×	494 2.5×	168 1.2×	89	1.6k
Shinya Tokuhiro Japan	13	556 1.1×	183 0.8×	194 1.0×	62 0.3×	165 1.1×	21	1.3k
Anne‐Marie L. Hogan Ireland	15	338 0.7×	288 1.2×	216 1.1×	371 1.9×	230 1.6×	18	1.4k
Qi-Huang Zheng United States	26	681 1.4×	367 1.6×	327 1.6×	354 1.8×	224 1.5×	93	1.9k
Tjeerd Barf Netherlands	19	724 1.5×	229 1.0×	267 1.3×	360 1.8×	161 1.1×	33	1.7k
Zhengxin Cai United States	22	367 0.7×	153 0.7×	361 1.8×	104 0.5×	59 0.4×	63	1.2k

Countries citing papers authored by Francesco Fiorentini

Since Specialization

Citations

This map shows the geographic impact of Francesco Fiorentini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Fiorentini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Fiorentini more than expected).

Fields of papers citing papers by Francesco Fiorentini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Fiorentini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Fiorentini. The network helps show where Francesco Fiorentini may publish in the future.

Co-authorship network of co-authors of Francesco Fiorentini

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Fiorentini. A scholar is included among the top collaborators of Francesco Fiorentini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Fiorentini. Francesco Fiorentini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartolucci, Roberta, et al.. (2024). In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients. CPT Pharmacometrics & Systems Pharmacology. 13(3). 359–373. 6 indexed citations

Garrone, Beatrice, et al.. (2023). PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK‐PD modeling from nonclinical to clinical development. Clinical and Translational Science. 16(4). 606–617. 6 indexed citations

Valsasina, Barbara, Paolo Orsini, Michele Caruso, et al.. (2023). Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies. Molecular Cancer Therapeutics. 22(12). 1465–1478. 4 indexed citations

Weiss, Glen J., Gayle Jameson, Daniel D. Von Hoff, et al.. (2017). Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors. Investigational New Drugs. 36(1). 85–95. 30 indexed citations

Adage, Tiziana, et al.. (2012). PA401, A Novel Decoy CXCL8- Based Biologic Therapeutic Reduces Lung Inflammation Induced By LPS As Well As Plasma Inflammatory Markers In Mice. A4172–A4172. 1 indexed citations

Caruso, Michele, Barbara Valsasina, Dario Ballinari, et al.. (2011). 5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(1). 96–101. 17 indexed citations

Beria, Italo, R Bossi, Maria Gabriella Brasca, et al.. (2011). NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(10). 2969–2974. 82 indexed citations

Albanese, Clara, Rachele Alzani, Nadia Amboldi, et al.. (2010). Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy. Molecular Cancer Therapeutics. 9(8). 2243–2254. 51 indexed citations

Locatelli, Giuseppe, Roberta Bosotti, Marina Ciomei, et al.. (2010). Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study. Molecular Cancer Therapeutics. 9(5). 1265–1273. 11 indexed citations

10.

Beria, Italo, Barbara Valsasina, Maria Gabriella Brasca, et al.. (2010). 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(22). 6489–6494. 26 indexed citations

11.

Rocchetti, Maria Teresa, Filippo Del Bene, Massimiliano Germani, et al.. (2009). Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach. European Journal of Cancer. 45(18). 3336–3346. 30 indexed citations

12.

Nesi, M., Daniela Borghi, Maria Gabriella Brasca, Francesco Fiorentini, & Paolo Pevarello. (2006). A practical synthesis of the major 3-hydroxy-2-pyrrolidinone metabolite of a potent CDK2/cyclin A inhibitor. Bioorganic & Medicinal Chemistry Letters. 16(12). 3205–3208. 4 indexed citations

13.

Jonge, Maja J.A. de, Jaap Verweij, Ate van der Gaast, et al.. (2002). Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours. European Journal of Cancer. 38(18). 2407–2415. 4 indexed citations

14.

Geroni, Cristina, Marina Ripamonti, Claudio Arrigoni, et al.. (2001). Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.. PubMed. 61(5). 1983–90. 17 indexed citations

15.

Fiorentini, Francesco, et al.. (2000). Pharmacokinetics of Single‐Dose Reboxetine in Volunteers with Renal Insufficiency. The Journal of Clinical Pharmacology. 40(5). 482–487. 19 indexed citations

16.

Fiorentini, Francesco, et al.. (1995). P-2-32 Action of reboxetine on selective drug metabolizing enzymes in rat liver. European Neuropsychopharmacology. 5(3). 285–285. 1 indexed citations

17.

Perrone, Roberto, Francesco Berardi, Nicola Antonio Colabufo, et al.. (1995). High Affinity and Selectivity on 5-HT1A Receptor of 1-Aryl-4-[(1-tetralin)alkyl]piperazines. 2. Journal of Medicinal Chemistry. 38(6). 942–949. 85 indexed citations

18.

Fiorentini, Francesco, Italo Poggesi, M.G. Jannuzzo, et al.. (1995). P-2-76 Effect of lorazepam on the pharmacokinetics of reboxetine in healthy volunteers. European Neuropsychopharmacology. 5(3). 300–300. 3 indexed citations

19.

Caruso, I, F Montrone, C. Davoli, et al.. (1994). Lornoxicam Versus Diclofenac In Rheumatoid-arthritis : A Double-blind, Multicenter Study. 11(3). 132–138. 14 indexed citations

20.

Perrone, Roberto, Francesco Berardi, Nicola Antonio Colabufo, et al.. (1994). Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 37(1). 99–104. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact